The_DT MRC_NP trial_NN of_IN assessment_NN and_CC management_NN of_IN older_JJR people_NNS in_IN the_DT community_NN :_: objectives_NNS ,_, design_NN and_CC interventions_NNS [_SYM ISRCTN23494848_NP ]_SYM Abstract_NP |_SYM Background_NN |_SYM The_DT benefit_NN of_IN regular_JJ multidimensional_JJ assessment_NN of_IN older_JJR people_NNS remains_VBZ controversial_JJ ._SENT The_DT majority_NN of_IN trials_NNS have_VBP been_VBN too_RB small_JJ to_TO produce_VB adequate_JJ evidence_NN to_TO inform_VB policy_NN ._SENT Despite_IN the_DT lack_NN of_IN a_DT firm_NN evidence_NN base_NN ,_, UK_NP primary_JJ care_NN practitioners_NNS (_( general_JJ practitioners_NNS )_) are_VBP required_VBN to_TO offer_VB an_DT annual_JJ health_NN check_NN to_TO patients_NNS aged_VBN 75_CD years_NNS and_CC over_IN ._SENT Design_NN |_SYM Cluster-randomised_JJ factorial_JJ trial_NN in_IN primary_JJ care_NN comparing_VBG a_DT package_NN of_IN assessments_NNS (_( i_NP )_) universal_JJ versus_CC targeted_JJ assessment_NN and_CC (_( ii_NN )_) management_NN by_IN the_DT primary_JJ care_NN team_NN (_( PC_NN )_) or_CC a_DT multidisciplinary_JJ geriatric_JJ assessment_NN team_NN (_( GM_NP )_) ._SENT The_DT unit_NN of_IN randomization_NN is_VBZ the_DT general_JJ practice_NN ._SENT Methods_NNS |_SYM Older_NP people_NNS aged_VBN 75_CD and_CC over_RB eligible_JJ for_IN the_DT over_IN 75s_JJ health_NN check_NN and_CC excluding_VBG those_DT in_IN nursing_NN homes_NNS or_CC terminally_RB ill_JJ were_VBD invited_VBN to_TO participate_VB ._SENT All_DT participants_NNS receive_VBP a_DT brief_JJ assessment_NN covering_VBG all_DT areas_NNS of_IN the_DT over_IN 75s_JJ check_NN ._SENT In_IN the_DT universal_JJ arm_NN all_DT participants_NNS also_RB receive_VBP a_DT detailed_JJ health_NN and_CC social_JJ assessment_NN by_IN a_DT study_NN nurse_NN while_IN in_IN the_DT targeted_JJ arm_NN only_JJ participants_NNS with_IN a_DT pre-determined_JJ number_NN and_CC range_NN of_IN problems_NNS at_IN the_DT brief_JJ assessment_NN go_VB on_RP to_TO have_VB the_DT detailed_JJ assessment_NN ._SENT The_DT study_NN nurse_NN follows_VBZ a_DT standard_JJ protocol_NN based_VBN on_IN results_NNS and_CC responses_NNS in_IN the_DT detailed_JJ assessment_NN to_TO make_VB referrals_NNS to_TO (_( i_NP )_) the_DT randomised_VBN management_NN team_NN (_( PC_NP or_CC GM_NP )_) (_( ii_NNS )_) other_JJ medical_JJ services_NNS ,_, health_NN care_NN workers_NNS or_CC agencies_NNS (_( iii_NP )_) emergency_NN referrals_NNS to_TO the_DT GP_NN ._SENT The_DT main_JJ outcomes_NNS are_VBP mortality_NN ,_, hospital_NN and_CC institutional_JJ admissions_NNS and_CC quality_NN of_IN life_NN ._SENT 106_CD practices_NNS and_CC 33,000_CD older_JJR people_NNS have_VBP been_VBN recruited_VBN to_TO the_DT trial_NN ._SENT Indications_NNS for_IN possible_JJ benefit_NN from_IN regular_JJ assessment_NN of_IN elderly_JJ people_NNS came_VBD from_IN early_JJ studies_NNS several_JJ decades_NNS ago_RB in_IN the_DT UK_NP which_WDT found_VBD high_JJ levels_NNS of_IN undetected_JJ problems_NNS in_IN elderly_JJ people_NNS and_CC highlighted_VBD the_DT need_NN for_IN a_DT systematic_JJ approach_NN to_TO problem_NN detection_NN ._SENT Around_IN the_DT same_JJ era_NN ,_, an_DT approach_NN emerged_VBD which_WDT emphasized_VBD function_NN and_CC disability_NN in_IN the_DT medical_JJ care_NN of_IN elderly_JJ people_NNS and_CC questionnaires_NNS were_VBD developed_VBN to_TO assist_VB in_IN the_DT assessment_NN of_IN a_DT range_NN of_IN physical_JJ ,_, mental_JJ and_CC social_JJ dimensions_NNS ._SENT Doubts_NNS about_IN the_DT feasibility_NN of_IN routine_JJ assessment_NN of_IN elderly_JJ people_NNS led_VBN to_TO the_DT notion_NN of_IN two_CD stage_NN targeted_JJ screening_NN to_TO identify_VB those_DT at_IN greatest_JJS risk_NN or_CC greatest_JJS need_VBP ._SENT In_IN the_DT 1980s_NNS results_NNS from_IN three_CD randomised_VBD controlled_JJ trials_NNS ,_, which_WDT examined_VBD the_DT benefit_NN of_IN socio-medical_JJ assessment_NN ,_, were_VBD published_VBN ._SENT Two_CD of_IN these_DT trials_NNS took_VBD place_NN in_IN the_DT UK_NP in_IN the_DT setting_NN of_IN general_JJ practice_NN and_CC one_CD in_IN Denmark_NP among_IN elderly_JJ people_NNS living_VBG in_IN the_DT community_NN ._SENT These_DT trials_NNS suggested_VBD some_DT possible_JJ benefits_NNS on_IN mortality_NN and_CC hospital_NN admissions_NNS (_( mainly_RB the_DT Danish_JJ trial_NN )_) but_CC none_NN of_IN the_DT trials_NNS provided_VBD convincing_JJ evidence_NN for_IN regular_JJ assessment_NN of_IN elderly_JJ people_NNS ._SENT Despite_IN these_DT equivocal_JJ results_NNS ,_, the_DT Department_NP of_IN Health_NP in_IN 1990_CD introduced_VBD a_DT contract_NN of_IN service_NN for_IN general_JJ practitioners_NNS ,_, which_WDT required_VBD them_PP to_TO offer_VB an_DT annual_JJ assessment_NN to_TO patients_NNS aged_VBN 75_CD years_NNS ,_, and_CC over_RB ._SENT Although_IN the_DT contract_NN specified_VBD the_DT broad_JJ areas_NNS for_IN assessment_NN ,_, the_DT method_NN ,_, level_NN and_CC nature_NN of_IN assessment_NN were_VBD not_RB defined_VBN ._SENT Different_JJ models_NNS of_IN initial_JJ assessment_NN have_VBP been_VBN used_VBN (_( e.g._FW postal_JJ ,_, lay_VB person_NN and_CC nurse_NN )_) and_CC targeted_JJ screening_NN has_VBZ been_VBN recommended_VBN but_CC none_NN of_IN these_DT strategies_NNS have_VBP been_VBN rigorously_RB evaluated_VBN and_CC compared_VBN ._SENT Models_NNS of_IN subsequent_JJ management_NN of_IN problems_NNS identified_VBN through_IN the_DT assessment_NN process_VBP also_RB require_VB evaluation_NN ._SENT In_IN studies_NNS conducted_VBN mainly_RB in_IN North_NP America_NP ,_, multidisciplinary_JJ teams_NNS in_IN the_DT hospital_NN setting_NN (_( usually_RB geriatrician_NN ,_, nurse_NN ,_, therapist_NN and_CC social_JJ worker_NN )_) appear_VBP to_TO offer_VB advantages_NNS in_IN terms_NNS of_IN survival_NN ,_, functional_JJ status_NN and_CC use_NN of_IN hospital_NN services_NNS ,_, but_CC the_DT costs_NNS and_CC benefits_NNS of_IN the_DT multidisciplinary_JJ team_NN as_IN a_DT integrated_JJ component_NN of_IN multidimensional_JJ assessment_NN ,_, when_WRB compared_VBN with_IN the_DT usual_JJ model_NN of_IN primary_JJ care_NN ,_, have_VBP yet_RB to_TO be_VB established_VBN ._SENT Table_NP 1_CD |_SYM Department_NP of_IN Health_NP Contract_NP of_IN Service_NP with_IN General_NP Practitioners_NP 1990_CD The_DT principal_JJ objective_NN of_IN the_DT MRC_NP trial_NN of_IN assessment_NN and_CC management_NN of_IN older_JJR people_NNS in_IN the_DT community_NN is_VBZ to_TO evaluate_VB a_DT package_NN of_IN multidimensional_JJ assessment_NN and_CC management_NN of_IN older_JJR people_NNS in_IN the_DT context_NN of_IN the_DT 1990_CD contract_NN of_IN service_NN ._SENT The_DT two_CD main_JJ components_NNS of_IN the_DT package_NN are_VBP the_DT method_NN of_IN assessment_NN --_: Universal_NP or_CC Targeted-_NP and_CC the_DT method_NN of_IN clinical_JJ management_NN --_: multidisciplinary_JJ geriatric_JJ team_NN (_( GM_NP )_) or_CC usual_JJ primary_JJ care_NN (_( PC_NN )_) ._SENT A_DT secondary_JJ objective_NN is_VBZ to_TO compare_VB different_JJ methods_NNS of_IN administering_VBG a_DT brief_JJ screening_NN questionnaire_NN (_( postal_JJ ,_, lay_VB or_CC nurse_VB )_) These_DT three_CD methods_NNS were_VBD chosen_VBN because_IN they_PP that_WDT had_VBD been_VBN advocated_VBN as_IN part_NN of_IN an_DT assessment_NN process_NN (_( 14_CD )_) (_( with_IN obvious_JJ differences_NNS in_IN cost_NN implications_NNS )_) but_CC no_DT formal_JJ evaluation_NN of_IN their_PP$ performance_NN in_IN a_DT single_JJ trial_NN has_VBZ been_VBN carried_VBN out_RP ._SENT We_PP were_VBD interested_JJ in_IN establishing_VBG whether_IN response_NN rates_NNS ,_, levels_NNS of_IN missing_VBG information_NN and_CC ,_, for_IN certain_JJ health_NN conditions_NNS ,_, sensitivity_NN and_CC specificity_NN compared_VBN to_TO measurements_NNS at_IN the_DT detailed_JJ assessment_NN ,_, varied_VBN for_IN the_DT three_CD methods_NNS ._SENT The_DT study_NN is_VBZ a_DT cluster-randomised_JJ trial_NN with_IN a_DT 2_CD x_SYM 2_CD factorial_JJ design_NN i.e._FW practices_NNS are_VBP randomised_VBN to_TO :_: Universal_JJ assessment_NN (_( plus_CC randomised_VBN to_TO GM_NP or_CC PC_NN )_) or_CC Targeted_NP (_( plus_CC randomised_VBN to_TO GM_NP or_CC PC_NN )_) ._SENT In_IN addition_NN to_TO the_DT main_JJ randomisations_NNS ,_, practices_NNS are_VBP also_RB randomised_VBN to_TO one_CD of_IN the_DT three_CD methods_NNS of_IN administering_VBG a_DT brief_JJ questionnaire_NN ,_, which_WDT are_VBP balanced_VBN across_IN the_DT main_JJ randomised_VBN groups_NNS ._SENT All_DT randomisation_NN is_VBZ at_IN the_DT level_NN of_IN the_DT general_JJ practice_NN ._SENT Figure_NP 1_CD |_SYM Design_NN of_IN MRC_NP trial_NN of_IN assessment_NN and_CC management_NN of_IN older_JJR people_NNS in_IN the_DT community_NN Design_NN of_IN MRC_NP trial_NN of_IN assessment_NN and_CC management_NN of_IN older_JJR people_NNS in_IN the_DT community_NN Description_NN of_IN procedures_NNS |_SYM All_DT practices_NNS administer_VBP a_DT brief_JJ assessment_NN questionnaire_NN to_TO participants_NNS in_IN the_DT study_NN either_CC by_IN post_NN ,_, or_CC by_IN a_DT layperson_NN ,_, or_CC by_IN a_DT nurse_NN ._SENT Following_VBG the_DT brief_JJ assessment_NN ,_, practices_NNS in_IN the_DT Universal_NP arm_NN carry_VBP out_RP a_DT detailed_JJ examination_NN by_IN the_DT study_NN nurse_NN in_IN all_DT patients_NNS (_( irrespective_RB of_IN their_PP$ responses_NNS on_IN the_DT brief_JJ assessment_NN )_) while_IN those_DT in_IN the_DT Targeted_JJ arm_NN carry_VB out_RP a_DT detailed_JJ assessment_NN only_RB in_IN those_DT patients_NNS who_WP "_`` trigger_NN "_'' on_IN the_DT brief_JJ assessment_NN ._SENT The_DT study_NN nurse_NN follows_VBZ a_DT standard_JJ protocol_NN based_VBN on_IN results_NNS and_CC responses_NNS in_IN the_DT detailed_JJ assessment_NN to_TO make_VB referrals_NNS to_TO (_( i_NP )_) the_DT randomised_VBN team_NN (_( PC_NP or_CC GM)(ii)_NP other_JJ medical_JJ services_NNS ,_, health_NN care_NN workers_NNS or_CC agencies_NNS (_( iii_NP )_) emergency_NN referrals_NNS to_TO the_DT GP_NN ._SENT Methods_NNS of_IN assessment_NN |_SYM The_DT brief_JJ assessment_NN questionnaire_NN |_SYM The_DT brief_JJ assessment_NN questionnaire_NN ,_, developed_VBN in_IN conjunction_NN with_IN Wallace_NP and_CC Williams_NP (_( who_WP have_VBP published_VBN the_DT binary_JJ response_NN version_NN of_IN the_DT questionnaire_NN )_) covers_VBZ all_PDT the_DT areas_NNS specified_VBN in_IN the_DT GP_NN contract_NN :_: social_JJ environment_NN ,_, activities_NNS of_IN daily_JJ living_NN ,_, sensory_JJ problems_NNS ,_, mobility_NN ,_, physical_JJ symptoms_NNS including_VBG continence_NN ,_, mental_JJ condition_NN ,_, use_NN of_IN medication_NN ._SENT We_PP chose_VBD to_TO use_VB a_DT graded_VBN response_NN scale_NN based_VBN on_IN the_DT results_NNS of_IN pilot_NN studies_NNS comparing_VBG graded_VBN with_IN binary_JJ responses_NNS ,_, which_WDT showed_VBD that_IN binary_JJ responses_NNS inflated_VBD positive_JJ responses_NNS and_CC that_IN patients_NNS had_VBD difficulty_NN making_VBG choices_NNS on_IN a_DT binary_JJ scale_NN ._SENT The_DT areas_NNS and_CC the_DT corresponding_JJ questions_NNS and_CC scale_NN are_VBP shown_VBN in_IN Table_NP ._SENT Additional_JJ questions_NNS on_IN alcohol_NN consumption_NN ,_, cigarette_NN smoking_NN and_CC physical_JJ activity_NN have_VBP been_VBN included_VBN for_IN epidemiological_JJ purposes_NNS ._SENT Criteria_NNS for_IN triggering_VBG to_TO the_DT detailed_JJ assessment_NN are_VBP 3_CD or_CC more_JJR problems_NNS identified_VBN from_IN the_DT brief_JJ assessment_NN or_CC any_DT one_CD of_IN 4_CD "_`` serious_JJ "_'' symptoms_NNS ._SENT According_VBG to_TO the_DT randomisation_NN ,_, patients_NNS are_VBP interviewed_VBN either_RB by_IN a_DT lay_JJ person_NN (_( usually_RB a_DT member_NN of_IN the_DT practice_NN staff_NN )_) or_CC the_DT study_NN nurse_NN or_CC the_DT questionnaire_NN is_VBZ mailed_VBN ._SENT Patients_NNS are_VBP invited_VBN to_TO attend_VB the_DT surgery_NN for_IN the_DT interview_NN but_CC are_VBP given_VBN the_DT option_NN of_IN the_DT interview_NN being_VBG carried_VBN out_RP at_IN home_NN ._SENT Identical_JJ questions_NNS are_VBP asked_VBN in_IN each_DT version_NN of_IN the_DT questionnaire_NN but_CC for_IN the_DT postal_JJ questionnaire_NN the_DT scoring_VBG of_IN the_DT triggers_NNS is_VBZ carried_VBN out_RP by_IN the_DT study_NN nurse_NN ._SENT The_DT postal_JJ questionnaire_NN was_VBD printed_VBN in_IN large_JJ font_NN to_TO permit_VB easy_JJ reading_NN ._SENT Table_NP 2_CD |_SYM The_DT brief_JJ assessment_NN questionnaire_NN areas_NNS ,_, specified_VBN in_IN the_DT GP_NN contract_NN and_CC corresponding_JJ questions_NNS The_DT detailed_JJ assessment_NN |_SYM Patients_NPS are_VBP invited_VBN to_TO attend_VB the_DT surgery_NN for_IN the_DT detailed_JJ assessment_NN but_CC are_VBP given_VBN the_DT option_NN of_IN the_DT assessment_NN being_VBG carried_VBN out_RP at_IN home_NN ._SENT The_DT detailed_JJ assessment_NN covers_VBZ the_DT same_JJ areas_NNS as_IN specified_VBN above_IN but_CC in_IN greater_JJR depth_NN for_IN example_NN ,_, whispered_VBN voice_NN test_NN for_IN hearing_NN ,_, Glasgow_NP Acuity_NP Cards_NP for_IN vision_NN ,_, Mini_NP Mental_NP State_NP Examination_NP for_IN cognitive_JJ impairment_NN ,_, the_DT Geriatric_NP Depression_NP Scale_NP ._SENT Additional_JJ questions_NNS include_VBP more_RBR detailed_JJ assessment_NN of_IN symptoms_NNS (_( e.g._FW Rose_NP chest_NN pain_NN questionnaire_NN for_IN possible_JJ angina_NN ,_, respiratory_JJ problems_NNS ,_, urinary_JJ and_CC faecal_JJ incontinence_NN ,_, examination_NN of_IN legs_NNS and_CC feet_NNS and_CC a_DT modified_JJ version_NN of_IN a_DT checklist_NN for_IN possible_JJ drug_NN interactions_NNS ._SENT Additional_JJ biological_JJ measurements_NNS include_VBP blood_NN pressure_NN ,_, heart_NN rate_NN ,_, and_CC dipstick_NN for_IN blood_NN ,_, protein_NN ,_, and_CC urine_NN ._SENT In_IN all_DT patients_NNS a_DT blood_NN sample_NN is_VBZ taken_VBN for_IN a_DT full_JJ biochemical_JJ screen_NN ._SENT Additional_JJ laboratory_NN investigations_NNS are_VBP triggered_VBN by_IN question_NN responses_NNS or_CC abnormal_JJ results_NNS e.g._FW faecal_JJ occult_JJ testing_NN for_IN a_DT positive_JJ response_NN to_TO a_DT question_NN on_IN blood_NN in_IN the_DT stools_NNS ,_, an_DT MSU_NP for_IN a_DT positive_JJ dipstick_NN result_NN for_IN protein_NN or_CC blood_NN ._SENT Patients_NNS are_VBP also_RB assessed_VBN for_IN social_JJ problems_NNS such_JJ as_IN financial_JJ difficulties_NNS ,_, social_JJ isolation_NN ._SENT The_DT choice_NN of_IN conditions_NNS to_TO screen_VB for_IN was_VBD based_VBN on_IN a_DT review_NN of_IN the_DT available_JJ literature_NN ._SENT The_DT study_NN nurse_NN follows_VBZ a_DT protocol_NN ,_, based_VBN on_IN results_NNS and_CC responses_NNS in_IN the_DT detailed_JJ assessment_NN ,_, to_TO make_VB referrals_NNS to_TO (_( i_NP )_) the_DT clinical_JJ teams_NNS (_( PC_NP or_CC GM_NP )_) (_( ii_NNS )_) other_JJ medical_JJ services_NNS ,_, health_NN care_NN workers_NNS or_CC agencies_NNS (_( iii_NP )_) emergency_NN referrals_NNS to_TO the_DT GP_NN ._SENT Referrals_NNS to_TO PC/GM_NP are_VBP for_IN serious_JJ clinical_JJ problems_NNS ,_, such_JJ as_IN depression_NN ,_, frequent_JJ falls_NNS ,_, abnormal_JJ biochemical_JJ results_NNS ,_, severe_JJ breathlessness_NN ,_, and_CC severe_JJ leg_NN oedema_NN ._SENT A_DT full_JJ list_NN is_VBZ given_VBN in_IN Table_NP ._SENT The_DT conditions_NNS for_IN referral_NN to_TO the_DT teams_NNS were_VBD based_VBN on_IN the_DT results_NNS of_IN a_DT survey_NN of_IN 90_CD general_JJ practitioners_NNS from_IN the_DT MRC_NP General_NP Practice_NP Research_NP Framework_NP (_( MRC_NP GPRF_NP )_) and_CC 52_CD geriatricians_NNS ,_, who_WP had_VBD indicated_VBN an_DT interest_NN in_IN taking_VBG part_NN in_IN the_DT study_NN ._SENT Other_JJ referrals_NNS are_VBP to_TO specialities_NNS or_CC professions_NNS for_IN a_DT variety_NN of_IN problems_NNS ,_, such_JJ as_IN ophthalmology_NN for_IN visual_JJ impairment_NN (_( not_RB due_JJ to_TO refractive_JJ errors_NNS )_) ,_, audiology_NN ,_, continence_NN advisors_NNS ,_, community_NN psychiatric_JJ nurse_NN ,_, social_JJ services_NNS ._SENT For_IN certain_JJ problems_NNS ,_, patients_NNS are_VBP advised_VBN to_TO seek_VB a_DT consultation_NN e.g._FW with_IN an_DT optician_NN for_IN refractive_JJ error_NN (_( VA<6/18_NP corrected_VBD with_IN pinhole_NN )_) ,_, or_CC to_TO a_DT dentist_NN for_IN problems_NNS with_IN mastication_NN ._SENT Table_NP 3_CD |_SYM Criteria_NN for_IN referral_NN to_TO primary_JJ care_NN team_NN (_( PC_NN )_) or_CC geriatric_JJ evaluation_NN and_CC management_NN team_NN (_( GM_NP )_) 1_CD Table_NP 4_CD |_SYM Detailed_JJ assessment_NN :_: referrals_NNS to_TO other_JJ health_NN professionals/agencies_NNS Management_NP teams_NNS |_SYM The_DT teams_NNS follow_VBP their_PP$ "_`` usual_JJ "_'' practice_NN and_CC there_EX was_VBD no_DT attempt_NN to_TO impose_VB a_DT formal_JJ protocol_NN ._SENT Information_NN is_VBZ collected_VBN on_IN investigations_NNS ,_, diagnoses_NNS ,_, services_NNS and_CC treatments_NNS that_WDT result_VBP from_IN the_DT referral_NN and_CC any_DT further_JJR referrals_NNS ._SENT Outcome_NN measures_NNS |_SYM The_DT principal_JJ outcome_NN measures_NNS for_IN hypothesis_NN testing_NN are_VBP mortality_NN ,_, hospital_NN and_CC institutional_JJ admissions_NNS and_CC quality_NN of_IN life_NN ._SENT Mortality_NN follow-up_NN is_VBZ achieved_VBN by_IN registering_VBG all_DT eligible_JJ patients_NNS with_IN ONS_NNS for_IN notification_NN of_IN death_NN ,_, date_NN and_CC cause_NN of_IN death_NN ._SENT Hospital_NN admissions_NNS are_VBP collected_VBN for_IN each_DT participant_NN for_IN a_DT 2-year_JJ period_NN from_IN the_DT time_NN of_IN the_DT brief_JJ assessment_NN using_VBG information_NN from_IN hospital_NN discharge_NN letters_NNS in_IN the_DT patients_NNS '_POS GP_NN records_NNS ._SENT Information_NP collected_VBD includes_VBZ specialty_NN ,_, dates_NNS of_IN admission_NN and_CC discharge_NN ,_, diagnoses_NNS ,_, specialty_NN of_IN consultant_NN ._SENT The_DT discharge_NN letter_NN is_VBZ considered_VBN to_TO be_VB a_DT reliable_JJ source_NN since_IN this_DT is_VBZ the_DT routine_JJ method_NN of_IN providing_VBG information_NN to_TO general_JJ practitioners_NNS from_IN hospital_NN services_NNS ._SENT Institutional_JJ admissions_NNS are_VBP collected_VBN on_IN an_DT ongoing_JJ basis_NN for_IN each_DT patient_NN from_IN the_DT date_NN of_IN the_DT baseline_JJ assessment_NN ._SENT Quality_NN of_IN Life_NP interviews_NNS are_VBP carried_VBN out_RP in_IN the_DT patient_NN 's_POS own_JJ homes_NNS by_IN fieldworkers_NNS who_WP are_VBP independent_JJ of_IN the_DT practice_NN ._SENT The_DT interviews_NNS take_VBP place_NN (_( i_NP )_) at_IN baseline_NN and_CC prior_RB to_TO the_DT assessment_NN (_( ii_NN )_) 18_CD months_NNS following_VBG the_DT baseline_JJ interview_NN (_( iii_NN )_) 36_CD months_NNS following_VBG the_DT baseline_NN ._SENT The_DT Quality_NP of_IN Life_NP core_JJ interview_NN schedule_NN includes_VBZ four_CD dimensions_NNS from_IN the_DT Sickness_NP Impact_NP Profile_NP (_( SIP_NP )_) (_( mobility_NN ,_, self-care_NN ,_, home-management_NN ,_, social_JJ interaction_NN )_) ,_, and_CC the_DT Philadelphia_NP Geriatric_NP Morale_NP Scale_NP (_( PGMS_NP )_) ,_, ,_, a_DT 17-item_JJ measure_NN of_IN morale_NN specifically_RB developed_VBN for_IN use_NN with_IN older_JJR people_NNS ._SENT We_PP used_VBD slightly_RB different_JJ follow-up_NN periods_NNS for_IN outcome_NN collection_NN since_IN we_PP would_MD expect_VB any_DT effect_NN on_IN hospital_NN admissions_NNS to_TO be_VB seen_VBN at_IN an_DT earlier_RBR rather_RB than_IN later_JJR stage_NN whereas_IN mortality_NN effect_NN might_MD show_VB some_DT lag_NN ._SENT Quality_NN of_IN life_NN is_VBZ measured_VBN both_CC at_IN 18_CD months_NNS and_CC at_IN 3_CD years_NNS ,_, which_WDT covers_VBZ the_DT same_JJ period_NN as_IN both_CC the_DT hospital_NN admissions_NNS and_CC the_DT mortality_NN ._SENT Use_NN of_IN services_NNS |_SYM Information_NN on_IN use_NN of_IN services_NNS is_VBZ being_VBG collected_VBN for_IN the_DT economic_JJ analysis_NN ._SENT Use_NN of_IN public_JJ sector_NN services_NNS (_( health_NN and_CC social_JJ services_NNS )_) is_VBZ collected_VBN through_IN two_CD sources_NNS (_( i_NP )_) in_IN the_DT quality_NN of_IN life_NN questionnaire_NN at_IN baseline_NN ,_, 18_CD and_CC 36_CD months_NNS )_) (_( ii_NNS )_) through_IN a_DT postal_JJ questionnaire_NN mailed_VBN to_TO randomly_RB selected_VBN cross_NN sectional_JJ samples_NNS of_IN patients_NNS at_IN 6_CD monthly_JJ intervals_NNS across_IN the_DT follow-up_NN period_NN ._SENT This_DT permits_VBZ us_PP to_TO have_VB information_NN both_CC from_IN a_DT longitudinal_JJ sample_NN over_IN the_DT 3_CD years_NNS of_IN the_DT trial_NN from_IN participants_NNS in_IN the_DT quality_NN of_IN life_NN sample_NN while_IN the_DT cross_NN sectional_JJ random_JJ sample_NN provides_VBZ a_DT more_RBR representative_JJ sample_NN across_IN the_DT follow-up_NN period_NN since_IN it_PP includes_VBZ those_DT those_DT who_WP may_MD die_VB or_CC leave_VB the_DT practice_NN ._SENT Trial_NN hypotheses_NNS and_CC sample_NN size_NN |_SYM Sample_NP size_NN methods_NNS |_SYM Sample_NP size_NN calculations_NNS for_IN mortality_NN and_CC hospital_NN admissions_NNS were_VBD calculated_VBN from_IN a_DT program_NN provided_VBN by_IN Martin_NP Shipley_NP at_IN University_NP College_NP London_NP ,_, Department_NP of_IN Epidemiology_NP ,_, using_VBG methods_NNS for_IN cluster_NN randomisation_NN described_VBN in_IN Shipley_NP et_CC al_NP and_CC under_IN the_DT assumption_NN that_IN the_DT rates_NNS follow_VBP a_DT Poisson_NP distribution_NN ._SENT The_DT program_NN uses_VBZ the_DT formula_NN where_WRB study_NN power_NN is_VBZ given_VBN by_IN 1-beta_NP ,_, Cbeta_NP is_VBZ the_DT critical_JJ value_NN of_IN the_DT normal_JJ distribution_NN in_IN the_DT upper_JJ tail_NN of_IN the_DT standard_JJ normal_JJ curve_NN ,_, Calpha/2_NP is_VBZ the_DT critical_JJ value_NN of_IN the_DT normal_JJ distribution_NN for_IN a_DT two_CD sided_VBN value_NN of_IN alpha_NN (_( in_IN our_PP$ case_NN taken_VBN to_TO be_VB alpha_NN =_SYM 0.01_CD )_) ,_, lambda_NN is_VBZ the_DT average_JJ value_NN of_IN the_DT underlying_VBG event_NN rate_NN ,_, Delta_NP is_VBZ the_DT difference_NN to_TO be_VB detected_VBN between_IN the_DT event_NN rate_NN in_IN the_DT main_JJ randomised_VBN groups_NNS of_IN the_DT trial_NN (_( universal_JJ minus_CC targeted_JJ or_CC GM_NP minus_CC PC_NP )_) ,_, 2_CD sigma2(1-kappa)_NN is_VBZ the_DT variance_NN of_IN the_DT underlying_VBG event_NN rates_NNS ,_, nH_NP is_VBZ the_DT harmonic_JJ mean_NN of_IN all_DT 2_CD m_NN sample_NN sizes_NNS and_CC 2_CD m_NN is_VBZ the_DT number_NN of_IN clusters_NNS ._SENT We_PP took_VBD the_DT conservative_JJ assumption_NN that_IN the_DT level_NN of_IN matching_VBG of_IN the_DT practices_NNS would_MD be_VB minimal_JJ or_CC essentially_RB zero_CD although_IN we_PP did_VBD attempt_NN to_TO balance_VB the_DT practices_NNS by_IN Jarman_NP score_NN and_CC SMR_NP by_IN stratified_VBN randomization_NN across_IN the_DT joint_JJ tertiles_NNS of_IN SMR_NP and_CC Jarman_NP ._SENT Expected_VBN mortality_NN rates_NNS were_VBD based_VBN on_IN ONS_JJ statistics_NNS for_IN England_NP and_CC Wales_NP with_IN an_DT adjustment_NN downwards_RB of_IN 0.7_CD of_IN the_DT background_NN mortality_NN rate_NN on_IN the_DT basis_NN that_IN the_DT trial_NN population_NN would_MD have_VB lower_JJR rates_NNS (_( healthy_JJ participant_NN effect_NN )_) ._SENT Rates_NNS of_IN hospital_NN admission_NN were_VBD adjusted_VBN down_RP on_IN the_DT basis_NN of_IN an_DT expected_VBN "_`` healthy_JJ "_'' participant_NN effect_NN and_CC additionally_RB on_IN the_DT basis_NN that_IN hospital_NN admissions_NNS might_MD be_VB under_IN reported_VBN and_CC that_IN annual_JJ rates_NNS do_VBP not_RB distinguish_VB between_IN persons_NNS and_CC admissions_NNS ._SENT For_IN hospital_NN admission_NN rates_NNS we_PP therefore_RB assumed_VBD that_IN the_DT rates_NNS might_MD be_VB a_DT half_NN of_IN those_DT published_VBN ._SENT Thus_RB in_IN both_DT calculations_NNS we_PP used_VBD conservative_JJ estimates_NNS of_IN the_DT rates_NNS ._SENT Sample_NN sizes_NNS for_IN institutional_JJ admissions_NNS could_MD not_RB be_VB calculated_VBN as_IN there_EX are_VBP no_DT national_JJ data_NNS on_IN rates_NNS of_IN institutional_JJ admission_NN ._SENT The_DT sample_NN size_NN calculations_NNS assumed_VBD an_DT average_NN of_IN 500_CD eligible_JJ patients_NNS per_IN cluster_NN followed_VBN for_IN an_DT average_NN of_IN 3_CD years_NNS ._SENT Sample_NN size_NN estimates_NNS for_IN the_DT quality_NN of_IN life_NN measures_NNS used_VBD the_DT formula_NN given_VBN by_IN Hsieh_NP based_VBN on_IN the_DT Z_NP approximation_NN ,_, N_NP =_SYM 8(Sb2_JJ +_SYM Sw2/m_NP )_) (_( zalpha/2_NN +_SYM zbeta)2/d2_JJ where_WRB N_NP is_VBZ the_DT total_JJ number_NN of_IN clusters_NNS ,_, Sb2_NP is_VBZ the_DT between_IN cluster_NN component_NN of_IN variance_NN ,_, Sw2_NP is_VBZ the_DT within_IN cluster_NN component_NN of_IN variance_NN ,_, m_NN is_VBZ the_DT number_NN of_IN individuals_NNS within_IN each_DT cluster_NN ,_, and_CC zalpha/2_NN and_CC zbeta/2_NN are_VBP the_DT critical_JJ points_NNS of_IN the_DT normal_JJ distribution_NN for_IN alpha_NN of_IN 0.01_CD and_CC 1-beta_NP of_IN 0.9_CD and_CC d_NN is_VBZ the_DT difference_NN between_IN randomised_VBN groups_NNS in_IN the_DT means_NN of_IN qol_NN scores_NNS ._SENT Estimates_NNS of_IN Sw2_NP and_CC d2_NP were_VBD based_VBN on_IN SIP_NP scores_NNS from_IN pilot_NN studies_NNS of_IN 52_CD older_JJR people_NNS attending_VBG geriatric_NN out_IN patient_JJ clinics_NNS and_CC POMS_NNS scores_NNS from_IN 115_CD patients_NNS on_IN the_DT care_NN of_IN the_DT elderly_JJ wards_NNS at_IN the_DT Hammersmith_NP Hospital_NP ._SENT We_PP expected_VBD 75_CD %_NN of_IN baseline_JJ responders_NNS to_TO provide_VB quality_NN of_IN life_NN data_NNS at_IN the_DT 3_CD year_NN end_NN point_NN (_( m_NN =_SYM 350_CD )_) ._SENT Since_IN no_DT data_NNS were_VBD available_JJ for_IN Sb2_NP (_( which_WDT is_VBZ expected_VBN to_TO be_VB considerably_RB smaller_JJR than_IN Sw2_NP )_) we_PP used_VBD varying_VBG estimates_NNS of_IN the_DT intraclass_JJ correlation_NN coefficient_NN (_( Sb2/_NP Sb2_NP +_SYM Sw2_NP )_) (_( 0.01_CD ,_, 0.02_CD ,_, 0.04_CD )_) ._SENT Estimates_NNS of_IN sample_NN size_NN |_SYM 108_CD practices_NNS (_( with_IN an_DT average_NN of_IN 500_CD patients_NNS aged_VBN 75_CD years_NNS and_CC over_IN )_) are_VBP required_VBN to_TO detect_VB differences_NNS between_IN Stage_NP 1_CD assessment_NN methods_NNS (_( targeted_VBN versus_IN universal_JJ )_) of_IN :_: at_IN least_JJS 15_CD %_NN in_IN mortality_NN assuming_VBG a_DT background_NN mortality_NN rate_NN of_IN approximately_RB 60/1000_CD person_NN years_NNS over_IN an_DT average_NN follow_VB up_RP period_NN of_IN 3_CD years_NNS ;_: at_IN least_JJS 10_CD %_NN in_IN 2_CD year_NN hospital_NN admissions_NNS assuming_VBG a_DT background_NN first_JJ admission_NN rate_NN of_IN 150/1000_CD person_NN years_NNS ._SENT This_DT sample_NN size_NN is_VBZ sufficient_JJ to_TO detect_VB differences_NNS between_IN the_DT two_CD management_NN strategies_NNS (_( GM_NP and_CC PC_NN )_) of_IN at_IN least_JJS 22_CD %_NN in_IN mortality_NN and_CC at_IN least_JJS 15_CD %_NN in_IN hospital_NN admissions_NNS ._SENT Smaller_JJR numbers_NNS of_IN practices_NNS are_VBP required_VBN to_TO detect_VB differences_NNS in_IN quality_NN of_IN life_NN ._SENT A_DT random_JJ sample_NN of_IN 24_CD practices_NNS is_VBZ adequate_JJ to_TO detect_VB differences_NNS between_IN Stage_NP 1_CD assessment_NN methods_NNS of_IN at_IN least_JJS 15_CD %_NN in_IN PGMS_NP and_CC SIP_NP and_CC between_IN GM_NP and_CC PC_NN of_IN at_IN least_JJS 25_CD %_NN in_IN PGMS_NP and_CC SIP_NP ._SENT The_DT size_NN of_IN the_DT effects_NNS to_TO be_VB tested_VBN were_VBD based_VBN on_IN previous_JJ trials_NNS and_CC a_DT realistic_JJ expectation_NN of_IN what_WP might_MD be_VB achievable_JJ and_CC of_IN public_JJ health_NN importance_NN ._SENT Trial_NN population_NN |_SYM The_DT trial_NN is_VBZ being_VBG conducted_VBN in_IN practices_NNS recruited_VBN through_IN the_DT MRC_NP GP_NN Research_NP Framework_NP with_IN list_NN sizes_NNS of_IN between_IN 200_CD and_CC 700_CD patients_NNS aged_VBN 75_CD years_NNS and_CC over_RB and_CC selected_VBN to_TO be_VB representative_JJ of_IN the_DT joint_JJ tertiles_NNS of_IN Jarman_NP and_CC Standard_NP Mortality_NP Ratios_NP (_( SMRs_NP )_) in_IN UK_NP practices_NNS ._SENT To_TO be_VB eligible_JJ for_IN randomisation_NN in_IN the_DT trial_NN ,_, recruited_VBD practices_NNS first_RB had_VBD to_TO obtain_VB the_DT agreement_NN of_IN the_DT local_JJ geriatrician_NN to_TO participate_VB (_( in_IN order_NN to_TO ensure_VB no_DT selection_NN bias_NN of_IN geriatricians_NNS in_IN practices_NNS subsequently_RB randomised_VBD to_TO GM_NP or_CC PC_NN )_) ._SENT Eligible_JJ patients_NNS were_VBD aged_VBN 75_CD years_NNS and_CC over_IN in_IN the_DT year_NN the_DT practice_NN undertook_VBD the_DT assessments_NNS ,_, excluding_VBG anyone_NN in_IN long-term_JJ care_NN or_CC with_IN terminal_JJ illness_NN ._SENT Patients_NNS in_IN residential_JJ or_CC sheltered_JJ accommodation_NN were_VBD included_VBN ._SENT Method_NN of_IN allocation_NN to_TO groups_NNS |_SYM Allocation_NN to_TO groups_NNS was_VBD by_IN a_DT computer_NN generated_VBD randomisation_NN list_NN ,_, stratified_VBN by_IN Jarman_NP and_CC SMR_NP tertile_NN as_IN practices_NNS were_VBD recruited_VBN to_TO the_DT trial_NN ._SENT Informed_JJ consent_NN |_SYM The_DT over_IN 75s_JJ check_NN is_VBZ a_DT contractual_JJ obligation_NN of_IN general_JJ practitioners_NNS ._SENT The_DT letter_NN of_IN invitation_NN to_TO the_DT study_NN was_VBD done_VBN in_IN the_DT context_NN of_IN the_DT letter_NN of_IN invitation_NN to_TO the_DT annual_JJ check_NN ._SENT The_DT letter_NN of_IN invitation_NN informed_VBD patients_NNS that_IN the_DT check_NN could_MD be_VB done_VBN as_IN part_NN of_IN a_DT research_NN study_NN with_IN a_DT brief_JJ description_NN of_IN the_DT intervention_NN (_( this_DT varied_JJ according_VBG to_TO the_DT practice_NN randomisation_NN )_) ._SENT Patients_NNS were_VBD given_VBN the_DT opportunity_NN to_TO have_VB the_DT check_NN carried_VBD out_RP in_IN the_DT usual_JJ way_NN and_CC reassured_VBD that_DT non-participation_NN in_IN the_DT study_NN would_MD not_RB affect_VB their_PP$ usual_JJ care_NN ._SENT Ethical_JJ approval_NN |_SYM Local_JJ Research_NP Ethics_NP Committee_NP approvals_NNS were_VBD obtained_VBN for_IN all_PDT the_DT practices_NNS participating_VBG in_IN the_DT trial_NN ._SENT Analysis_NN |_SYM The_DT principal_JJ analysis_NN is_VBZ of_IN the_DT components_NNS of_IN the_DT package_NN of_IN interventions_NNS and_CC therefore_RB all_DT analyses_NNS will_MD take_VB account_NN of_IN the_DT other_JJ main_JJ randomisation_NN ._SENT The_DT results_NNS will_MD be_VB presented_VBN for_IN (_( i_NP )_) universal_JJ versus_CC targettted_JJ (_( ii_NP )_) GM_NP versus_CC PC_NP ._SENT In_IN order_NN to_TO ensure_VB that_IN the_DT method_NN of_IN administering_VBG the_DT brief_JJ questionnaire_NN does_VBZ not_RB influence_VB the_DT main_JJ randomisations_NNS ,_, the_DT analyses_NNS will_MD also_RB be_VB adjusted_VBN for_IN the_DT '_'' nurse_NN vs._IN lay_JJ vs._CC postal_JJ '_'' randomised_VBN intervention_NN ._SENT The_DT primary_JJ population_NN for_IN analysis_NN is_VBZ the_DT "_`` Intention_NN to_TO Treat_NP "_'' population_NN (_( i.e._FW all_PDT those_DT eligible_NN for_IN the_DT trial_NN and_CC invited_VBN to_TO take_VB part_NN irrespective_RB of_IN participation_NN )_) ._SENT Pre-specified_JJ covariates_NNS are_VBP age_NN ,_, sex_NN and_CC (_( at_IN practice_NN level_NN )_) SMR_NP and_CC Jarman_NP score_NN ._SENT There_EX will_MD be_VB no_DT sub-group_NN analyses_NNS in_IN the_DT primary_JJ analysis_NN ._SENT All_DT analyses_NNS will_MD take_VB account_NN of_IN cluster_NN randomisation_NN which_WDT has_VBZ the_DT effect_NN of_IN increasing_VBG the_DT standard_JJ errors_NNS of_IN the_DT estimates_NNS and_CC therefore_RB it_PP is_VBZ unlikely_JJ that_IN spurious_JJ significant_JJ effects_NNS will_MD be_VB detected_VBN ._SENT Secondary_JJ analyses_NNS will_MD be_VB conducted_VBN as_RB above_IN on_IN the_DT "_`` per_FW protocol_NN population_NN "_`` Economic_JJ analysis_NN |_SYM The_DT primary_JJ objective_NN of_IN the_DT economic_JJ analysis_NN is_VBZ to_TO determine_VB the_DT relative_JJ costs_NNS and_CC costs_NNS per_IN life_NN year_NN gained_VBD of_IN the_DT different_JJ components_NNS of_IN the_DT assessment_NN and_CC management_NN packages_NNS ._SENT Cost_NN analysis_NN will_MD compare_VB the_DT direct_JJ health_NN and_CC social_JJ care_NN costs_NNS of_IN assessments_NNS and_CC the_DT longer_JJR term_NN costs_NNS of_IN care_NN and_CC treatment_NN following_VBG the_DT interventions_NNS (_( use_NN of_IN services_NNS ,_, hospital_NN admissions_NNS ,_, and_CC instiututional_JJ admissions_NNS )_) ._SENT Service_NN use_NN data_NNS over_IN the_DT follow-up_NN period_NN of_IN the_DT trial_NN will_MD be_VB obtained_VBN from_IN longitudinal_JJ samples_NNS (_( as_IN part_NN of_IN the_DT quality_NN of_IN life_NN questionnaire_NN )_) and_CC from_IN the_DT repeated_JJ cross_NN sectional_JJ samples_NNS ._SENT Progress_NN on_IN trial_NN |_SYM 109_CD practices_NNS were_VBD randomised_VBN and_CC study_NN staff_NN trained_VBN in_IN the_DT study_NN protocol_NN ;_: three_CD practices_NNS withdrew_VBD before_IN carrying_VBG out_RP any_DT of_IN the_DT study_NN interventions_NNS (_( one_CD of_IN these_DT was_VBD also_RB randomised_VBN to_TO the_DT quality_NN of_IN life_NN collection_NN )_) ._SENT It_PP was_VBD too_RB late_JJ to_TO replace_VB these_DT practices_NNS so_IN the_DT final_JJ achieved_VBN target_NN is_VBZ 3_CD practices_NNS short_JJ ._SENT 106_CD practices_NNS and_CC 33,000_CD patients_NNS are_VBP participating_VBG in_IN the_DT trial_NN ._SENT The_DT practices_NNS are_VBP equally_RB distributed_VBN over_IN the_DT Universal_NP (_( n_NN =_SYM 53_CD )_) or_CC Targeted_NP (_( n_NN =_SYM 53_CD )_) arms_NNS and_CC of_IN the_DT PC_NN (_( n_NN =_SYM 53_CD )_) or_CC GM_NP (_( n_NN =_SYM 53_CD )_) arms_NNS of_IN the_DT trial_NN ._SENT This_DT trial_NN is_VBZ ,_, by_IN far_RB ,_, the_DT largest_JJS and_CC most_RBS comprehensive_JJ study_NN internationally_RB to_TO examine_VB the_DT benefits_NNS of_IN multidimensional_JJ assessment_NN of_IN older_JJR people_NNS in_IN the_DT community_NN ._SENT Although_IN a_DT number_NN of_IN trials_NNS have_VBP been_VBN published_VBN since_IN the_DT introduction_NN of_IN the_DT 1990_CD contract_NN ,_, including_VBG three_CD from_IN the_DT UK_NP ,_, they_PP have_VBP ,_, in_IN common_JJ with_IN previous_JJ trials_NNS ,_, been_VBN too_RB small_JJ to_TO produce_VB results_NNS of_IN sufficient_JJ precision_NN and_CC certainty_NN to_TO inform_VB policy_NN decisions_NNS ._SENT Studies_NNS conducted_VBN in_IN the_DT US_NP are_VBP difficult_JJ to_TO translate_VB to_TO the_DT UK_NP health_NN care_NN setting_NN ._SENT Previous_JJ trials_NNS have_VBP also_RB suffered_VBN from_IN a_DT number_NN of_IN other_JJ methodological_JJ problems_NNS :_: individual_JJ patient_JJ randomisation_NN in_IN the_DT same_JJ healthcare_NN setting_NN (_( e.g._FW general_JJ practice_NN )_) which_WDT may_MD lead_VB to_TO contamination_NN of_IN randomised_VBN groups_NNS and_CC dilution_NN of_IN effect_NN ;_: lack_NN of_IN a_DT clearly_RB defined_VBN protocol_NN for_IN intervention_NN and_CC referral_NN ;_: and_CC (_( in_IN the_DT US_NP studies_NNS )_) low_JJ participation_NN rates_NNS and_CC over-representation_NN of_IN fit_JJ older_JJR people_NNS ._SENT One_CD systematic_JJ review_NN and_CC three_CD meta_NN analyses_NNS of_IN these_DT trials_NNS have_VBP been_VBN published_VBN ,_, but_CC have_VBP come_VBN to_TO different_JJ conclusions_NNS concerning_VBG benefits_NNS on_IN major_JJ outcomes_NNS ,_, such_JJ as_IN mortality_NN and_CC hospital_NN admissions_NNS ._SENT Our_PP$ trial_NN avoids_VBZ some_DT of_IN these_DT design_NN problems_NNS by_IN employing_VBG :_: randomisation_NN at_IN the_DT general_JJ practice_NN level_NN ,_, which_WDT reduces_VBZ the_DT possibility_NN of_IN contamination_NN ;_: clearly_RB defined_VBN protocols_NNS for_IN the_DT intervention_NN and_CC referrals_NNS ;_: minimal_JJ exclusion_NN criteria_NNS (_( terminally_RB ill_JJ or_CC in_IN institutional_JJ care_NN )_) ;_: high_JJ power_NN to_TO test_VB hypotheses_NNS on_IN major_JJ outcomes_NNS ._SENT These_DT outcomes_NNS were_VBD chosen_VBN because_IN a_DT number_NN of_IN trials_NNS had_VBD suggested_VBN possible_JJ benefits_NNS on_IN mortality_NN ,_, institutional_JJ (_( or_CC nursing_NN home_NN )_) and_CC hospital_NN admissions_NNS ._SENT Individual_JJ studies_NNS and_CC meta_NN analyses_NNS have_VBP also_RB looked_VBN at_IN outcomes_NNS such_JJ as_IN functional_JJ decline_NN or_CC physical_JJ morbidity_NN --_: we_PP used_VBD comparable_JJ domains_NNS of_IN health_NN related_JJ quality_NN of_IN life_NN as_IN an_DT outome_NN to_TO capture_VB these_DT aspects_NNS and_CC also_RB included_VBD morale_NN and_CC social_JJ interaction_NN as_IN other_JJ relevant_JJ outcomes_NNS ._SENT Our_PP$ trial_NN compares_VBZ different_JJ strategies_NNS of_IN multidimensional_JJ geriatric_JJ assessment_NN ._SENT These_DT different_JJ levels_NNS are_VBP analogous_JJ to_TO the_DT different_JJ intensities_NNS of_IN screening_NN described_VBN by_IN Stuck_NP and_CC colleagues_NNS in_IN their_PP$ recent_JJ meta_NN analysis_NN (_( 33_CD )_) ,_, for_IN example_NN universal_JJ assessment_NN with_IN management_NN by_IN a_DT specialist_JJ geriatric_JJ team_NN in_IN our_PP$ trial_NN is_VBZ comparable_JJ to_TO their_PP$ category_NN of_IN "_`` multidimensional_JJ geriatric_JJ assessment_NN and_CC follow-up_NN "_'' in_IN the_DT meta-analysis_NN ._SENT Hence_RB our_PP$ results_NNS are_VBP applicable_JJ across_IN differing_VBG health_NN care_NN contexts_NNS ._SENT Our_PP$ trial_NN interventions_NNS and_CC referrals_NNS across_IN a_DT broad_JJ range_NN of_IN health_NN care_NN professionals_NNS and_CC other_JJ agencies_NNS address_VBP disability_NN and_CC impairment_NN as_RB well_RB as_IN disease_NN which_WDT we_PP consider_VBP to_TO be_VB an_DT appropriate_JJ balance_NN rather_RB than_IN adopting_VBG either_CC a_DT purely_RB medical_JJ or_CC functional_JJ model_NN of_IN health_NN at_IN older_JJR ages_NNS ._SENT There_EX are_VBP a_DT number_NN of_IN limitations_NNS of_IN our_PP$ trial_NN ._SENT Cluster_NN randomisation_NN trials_NNS require_VBP substantially_RB greater_JJR numbers_NNS than_IN trials_NNS of_IN individual_JJ randomisation_NN ,_, and_CC are_VBP more_RBR susceptible_JJ to_TO practice_VB effects_NN e.g._FW loss_NN of_IN all_DT patients_NNS to_TO follow-up_NN if_IN a_DT practice_NN withdraws_VBZ ._SENT The_DT large_JJ numbers_NNS also_RB made_VBD certain_JJ aspects_NNS of_IN data_NN collection_NN prohibitively_RB expensive_JJ ._SENT For_IN this_DT reason_NN we_PP have_VBP not_RB collected_VBN any_DT detailed_JJ information_NN on_IN services_NNS and_CC treatments_NNS already_RB being_VBG received_VBN by_IN trial_NN participants_NNS ie_NN prior_RB to_TO the_DT trial_NN interventions_NNS ,_, although_IN we_PP will_MD have_VB some_DT limited_JJ information_NN on_IN these_DT if_IN part_NN of_IN the_DT criteria_NNS for_IN referral_NN ._SENT Also_RB ,_, funding_NN did_VBD not_RB permit_VB collection_NN on_IN hospital_NN admissions_NNS over_IN a_DT longer_JJR period_NN ._SENT Nor_CC were_VBD we_PP able_JJ ,_, for_IN costs_NNS reasons_NNS ,_, to_TO repeat_VB the_DT intervention_NN packages_NNS over_IN several_JJ years_NNS or_CC ,_, to_TO examine_VB the_DT benefits_NNS of_IN annual_JJ assessment_NN versus_IN some_DT other_JJ time_NN period_NN such_PDT a_DT triennial_JJ assessment_NN ._SENT A_DT further_JJR limitation_NN of_IN our_PP$ trial_NN design_NN was_VBD that_IN it_PP was_VBD not_RB possible_JJ to_TO have_VB a_DT control_NN group_NN (_( i.e._FW a_DT group_NN randomised_VBD to_TO no_DT intervention_NN )_) because_IN of_IN the_DT contractual_JJ obligation_NN of_IN general_JJ practitioners_NNS to_TO offer_VB an_DT annual_JJ health_NN check_NN to_TO the_DT over_IN 75s_NP ._SENT It_PP is_VBZ extremely_RB unfortunate_JJ that_IN this_DT policy_NN was_VBD introduced_VBN (_( despite_IN the_DT lack_NN of_IN a_DT firm_NN evidence_NN base_NN )_) because_IN it_PP has_VBZ meant_VBN that_IN a_DT properly_RB controlled_VBN study_NN cannot_MD be_VB conducted_VBN in_IN the_DT UK_NP ._SENT As_RB with_IN other_JJ trials_NNS ,_, especially_RB in_IN health_NN services_NNS research_NN ,_, there_EX are_VBP issues_NNS of_IN generalisability_NN of_IN the_DT results_NNS to_TO other_JJ relevant_JJ health_NN care_NN professionals_NNS (_( practice_NN nurses_NNS ,_, general_JJ practitioners_NNS and_CC geriatricians_NNS )_) and_CC to_TO patients_NNS ._SENT The_DT practices_NNS in_IN the_DT trial_NN belong_VBP to_TO the_DT MRC_NP General_NP Practice_NP Research_NP Framework_NP and_CC ,_, although_IN the_DT patients_NNS in_IN those_DT practices_NNS were_VBD representative_JJ of_IN the_DT wider_JJR patient_NN population_NN (_( in_IN terms_NNS of_IN deprivation_NN and_CC mortality_NN )_) ,_, the_DT general_JJ practitioners_NNS have_VBP a_DT interest_NN in_IN being_VBG involved_VBN in_IN research_NN ._SENT However_RB we_PP have_VBP no_DT reason_NN to_TO believe_VB that_IN the_DT general_JJ practitioners_NNS or_CC the_DT nurses_NNS had_VBD any_DT particular_JJ expertise_NN in_IN geriatric_JJ assessment_NN or_CC management_NN ._SENT The_DT geriatricians_NNS were_VBD recruited_VBN to_TO the_DT study_NN by_IN virtue_NN of_IN being_VBG the_DT linked_VBN local_JJ geriatric_JJ service_NN to_TO the_DT general_JJ practice_NN and_CC were_VBD not_RB selected_VBN for_IN any_DT particular_JJ expertise_NN or_CC experience_NN in_IN research_NN ._SENT Ensuring_VBG agreement_NN of_IN the_DT local_JJ geriatricians_NNS to_TO take_VB part_NN in_IN principal_NN ,_, which_WDT was_VBD a_DT criterion_NN for_IN randomisation_NN of_IN the_DT practice_NN (_( i.e._FW before_IN knowledge_NN of_IN whether_IN the_DT practice_NN was_VBD randomised_VBN to_TO PC_NN or_CC GM_NP )_) ,_, reduced_VBD the_DT likelihood_NN of_IN selection_NN bias_NN of_IN geriatricians_NNS ._SENT Nonetheless_RB it_PP will_MD be_VB important_JJ to_TO describe_VB the_DT clinical_JJ management_NN through_IN the_DT collection_NN of_IN process_NN information_NN so_RB that_IN ,_, if_IN the_DT trial_NN shows_VBZ a_DT benefit_NN for_IN a_DT particular_JJ package_NN of_IN assessment_NN and_CC management_NN ,_, its_PP$ components_NNS can_MD be_VB described_VBN ._SENT The_DT trial_NN results_NNS are_VBP also_RB of_IN direct_JJ relevance_NN to_TO the_DT "_`` single_JJ assessment_NN "_'' recommended_VBN by_IN the_DT National_NP Service_NP Frameworks_NP for_IN Older_NP people_NNS ,_, in_IN particular_RB the_DT decision_NN on_IN how_WRB and_CC to_TO whom_WP the_DT brief_JJ overview_NN assessment_NN should_MD be_VB targeted_VBN ._SENT The_DT levels_NNS of_IN benefit_NN to_TO be_VB tested_VBN in_IN the_DT trial_NN ,_, if_IN demonstrated_VBN ,_, will_MD result_VB in_IN important_JJ reductions_NNS in_IN mortality_NN ,_, hospital_NN and_CC institutional_JJ admissions_NNS and_CC improved_VBN quality_NN of_IN life_NN ._SENT These_DT results_NNS will_MD be_VB relevant_JJ ,_, not_RB only_RB to_TO the_DT UK_NP older_JJR population_NN but_CC also_RB to_TO many_JJ other_JJ countries_NNS and_CC settings_NNS where_WRB health_NN care_NN of_IN older_JJR people_NNS has_VBZ become_VBN a_DT policy_NN priority_NN ._SENT None_NN declared_VBD All_DT authors_NNS contributed_VBD to_TO the_DT design_NN of_IN the_DT trial_NN ._SENT AF_NNS wrote_VBD the_DT manuscript_NN and_CC DJ_NP ,_, CB_NP and_CC AT_NP provided_VBD comments_NNS ._SENT All_DT authors_NNS approved_VBD the_DT final_JJ manuscript_NN ._SENT publication_NN history_NN :_: The_DT pre-publication_NN history_NN for_IN this_DT paper_NN can_MD be_VB accessed_VBN here_RB :_: 